Nicole Ling, MD, MAS

  1. Wang CS, Sadun RE, Zhou W, Miller KR, Ardoin SP, Bearer C, Hause E, Hui-Yuen J, Ling N, Pereira M, Riebschleger M, Rouster-Stevens K, Sarkissian A, Shalen J, Soulsby WD, Twilt M, Wu EY, Lewandowski LB, Wenderfer SE, Cooper JC, Childhood Arthritis and Rheumatology Research Alliance Lupus Nephritis Working Group. Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus Nephritis. ACR Open Rheumatology 2025. PMID: 41294283


  2. Muniyappa A, Weia B, Ling N, O'Brien J, Tamerat M, Soulsby WD, Yim J, Oates A. A novel approach to patient portal activation data to power equity improvements. Journal of the American Medical Informatics Association : JAMIA 2024. PMID: 38887009



  3. Wang CS, Sadun RE, Zhou W, Miller KR, Pyle L, Ardoin SP, Bacha C, Hause E, Hui-Yuen J, Ling N, Pereira M, Riebschleger M, Rouster-Stevens K, Sarkissian A, Shalen J, Soulsby W, Twilt M, Wu EY, Lewandowski LB, Wenderfer SE, Cooper JC, Childhood Arthritis and Rheumatology Research Alliance (CARRA) Lupus Nephritis Working Group. Renal Response Outcomes of the EuroLupus and NIH Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis. Arthritis & rheumatology (Hoboken, N.J.) 2023. PMID: 37800549


  4. El-Haj N, HarnEnz Z, Singer ST, Kim S, Cham E, Ling N, Karakas SP, Nguyen VA, Petru AM. From Microcytosis to Macrodiagnosis. Pediatrics 2021. PMID: 34326177